外泌体:一种通过货物递送调节耐药性的重要介质。
Exosomes: a significant medium for regulating drug resistance through cargo delivery.
作者信息
Ren Bixuan, Li Xiaoqing, Zhang Zhihua, Tai Sheng, Yu Shan
机构信息
Department of Hepatic Surgery, Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Department of Pathology, Second Affiliated Hospital of Harbin Medical University, Harbin, China.
出版信息
Front Mol Biosci. 2024 Jul 29;11:1379822. doi: 10.3389/fmolb.2024.1379822. eCollection 2024.
Exosomes are small lipid nanovesicles with a diameter of 30-150 nm. They are present in all body fluids and are actively secreted by the majority of cells through the process of exocytosis. Exosomes play an essential role in intercellular communication and act as significant molecular carriers in regulating various physiological and pathological processes, such as the emergence of drug resistance in tumors. Tumor-associated exosomes transfer drug resistance to other tumor cells by releasing substances such as multidrug resistance proteins and miRNAs through exosomes. These substances change the cell phenotype, making it resistant to drugs. Tumor-associated exosomes also play a role in impacting drug resistance in other cells, like immune cells and stromal cells. Exosomes alter the behavior and function of these cells to help tumor cells evade immune surveillance and form a tumor niche. In addition, exosomes also export substances such as tumoricidal drugs and neutralizing antibody drugs to help tumor cells resist drug therapy. In this review, we summarize the mechanisms of exosomes in promoting drug resistance by delivering cargo in the context of the tumor microenvironment (TME).
外泌体是直径为30 - 150纳米的小型脂质纳米囊泡。它们存在于所有体液中,并通过胞吐作用由大多数细胞主动分泌。外泌体在细胞间通讯中发挥着重要作用,并且在调节各种生理和病理过程(如肿瘤中耐药性的出现)中作为重要的分子载体。肿瘤相关外泌体通过外泌体释放多药耐药蛋白和微小RNA等物质,将耐药性传递给其他肿瘤细胞。这些物质改变细胞表型,使其对药物产生抗性。肿瘤相关外泌体在影响其他细胞(如免疫细胞和基质细胞)的耐药性方面也发挥作用。外泌体改变这些细胞的行为和功能,以帮助肿瘤细胞逃避免疫监视并形成肿瘤微环境。此外,外泌体还输出杀肿瘤药物和中和抗体药物等物质,以帮助肿瘤细胞抵抗药物治疗。在本综述中,我们总结了外泌体在肿瘤微环境(TME)背景下通过传递货物促进耐药性的机制。
相似文献
Front Mol Biosci. 2024-7-29
Discoveries (Craiova). 2014-9-25
Int J Cancer. 2017-3-11
J Hematol Oncol. 2015-7-10
Cancer Drug Resist. 2022-6-21
Biomed Res Int. 2019-12-11
Biochim Biophys Acta Rev Cancer. 2021-1
引用本文的文献
Front Immunol. 2025-7-17
IBRO Neurosci Rep. 2025-2-5
本文引用的文献
CNS Neurosci Ther. 2023-8
Nat Rev Mol Cell Biol. 2023-7
Trends Cell Biol. 2023-8
Int J Mol Sci. 2023-1-10
Mol Cancer. 2022-11-1